System 8000 Base Product Usage: The Sarns Modular Perfusion System 8000 is indicated for use for up to 6 hours on the extracorporeal circulation of blood for arterial perfusion, regional perfusion, and cardiopulmonary bypass procedures, when used by a qualified medical professional who is experienced in the operation of this or similar equipment.
Publicado el 22 de agosto de 2012 · Inicio del retiro: 20 de junio de 2012
Resumen
FDA registra el retiro Z-2218-2012 de dispositivos médicos de Clase III, publicado el 22 de agosto de 2012 e iniciado el 20 de junio de 2012. Empresa responsable: Terumo Cardiovascular Systems Corporation; Estado: Finalizado; Cantidad reportada: 3; Lote: catalog number: 16401 and serial number: 2001, 2002, and 2003. La Clase III indica que no es probable que el producto cause consecuencias adversas para la salud.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
During a retrospective review of complaint events, TCVS identified on 06/15/12 that three (3) Sarns" System 8000 bases were manufactured and distributed from 11/13/06-11/29/06 with an incorrect incorrect amperage rating identified on the name plate label. The mislabeling was identified in January 2007 a set up process of the automark label printer. All units were corrected in the field in Marc
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Terumo Cardiovascular Systems Corporation
- Distribuidor
- US Nationwide Distribution - including the state of New York
- Lote
- catalog number: 16401 and serial number: 2001, 2002, and 2003.
- Clasificación de riesgo
- Class III
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDACDI OneView System BPM Probe: Cat. No. CDI753 - CDI OneView BPM Probe, Cat. No. CDI753TK - CDI OneView BPM2 de julio de 2025
- FDACardiovascular Procedure Kits that include High Crack Check Valve PN 205307A Part Number: 6375 16010 6297410 de abril de 2024
- FDA(1) Capiox FX25 (West) Advance Oxygenator- with left port, 4-liter Reservoir, XC modified to Advance, Sterile23 de diciembre de 2020
- FDATerumo Capiox NX19 Oxygenator With Reservoir (East Orientation) P/N: 3CX*NX19RE7 de agosto de 2019
- FDACustom Access Tray, Sterile, contains Sodium Chloride 0.9% 50 mL, Re-order #: CMS-1667-R2(94-2478),29 de agosto de 2012
- FDADePuy Custom Implant Devices Packaging: Packaging was not standardized on customs, it was dependant on the22 de agosto de 2012
Preguntas sobre este retiro
¿System 8000 Base Product Usage: The Sarns Modular Perfusion System 8000 is indicated for use for up to 6 hours on the extracorporeal circulation of blood for arterial perfusion, regional perfusion, and cardiopulmonary bypass procedures, when used by a qualified medical professional who is experienced in the operation of this or similar equipment. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2218-2012 el 22 de agosto de 2012. Peligro reportado: During a retrospective review of complaint events, TCVS identified on 06/15/12 that three (3) Sarns" System 8000 bases were manufactured and distributed from 11/13/06-11/29/06 with an incorrect incorrect amperage rating identified on the name plate label. The mislabeling was identified in January 2007 a set up process of the automark label printer. All units were corrected in the field in Marc
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter